Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
7 pending office actions • 5 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
Jilin University currently manages 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 7 distinct examiners, which suggests a broad range of technical review across the patent office. This distribution ensures that no single examiner's specific tendencies dominate the university's current prosecution landscape. The variety of examiners involved may lead to different prosecution timelines and outcomes for the pending applications.
The portfolio is active across 5 distinct art units, reflecting the diverse technical nature of the university's research and development efforts. Rodney T. Frank is identified as the busiest examiner for the entity, although he is responsible for only 1 pending office action. This indicates a highly decentralized prosecution environment where each pending matter is likely receiving specialized attention from different examiners and art units. Practitioners should prepare for varied feedback across these 5 distinct art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (14%) |
| §101 + other | 2 (29%) |
| §103 only | 1 (14%) |
| §112 only | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRANK, RODNEY T | 1 | 72.7% | +3.6% |
| SATANOVSKY, ALEXANDER | 1 | 56.7% | +19.1% |
| TIMILSINA, SHARAD | 1 | 74.4% | +11.1% |
| MALEVIC, DJURA | 1 | 78.1% | +9.8% |
| DUNN, MCKENZIE A | 1 | 53.8% | +56.3% |
| ANGELL, JON E | 1 | 71.0% | +21.1% |
| STUBBS, JOHN THOMAS | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17834161 | CROP YIELD PREDICTION METHOD AND SYSTEM | STUBBS, JOHN THOMAS | 2d overdue |
| 18758054 | SOIL NITROGEN CONTENT SOFT MEASUREMENT METHOD BASED ON THE CONTROL SYSTEM FOR ON-DEMAND FERTILIZATION OF CORN | SATANOVSKY, ALEXANDER | — |
| 18622962 | CHIP-LEVEL POSITIONING METHOD FOR ORTHOPEDIC SURGERY NAVIGATION BASED ON ULTRA-WIDE BANDWIDTH | TIMILSINA, SHARAD | — |
| 18037057 | APPLICATION OF SCTAG IN PREPARATION OF KIT USED TO DIAGNOSE GASTRIC CANCER | DUNN, MCKENZIE A | — |
| 18349353 | APPLICATION OF ANTISENSE OLIGONUCLEOTIDE TARGETING PBX1 PROMOTER REGION G-QUADRUPLEX IN PREPARATION OF MEDICINE FOR TREATING MELANOMA | ANGELL, JON E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18758054 | SOIL NITROGEN CONTENT SOFT MEASUREMENT METHOD BASED ON THE CONTROL SYSTEM FOR ON-DEMAND FERTILIZATION OF CORN | SATANOVSKY, ALEXANDER | — |
| 18622962 | CHIP-LEVEL POSITIONING METHOD FOR ORTHOPEDIC SURGERY NAVIGATION BASED ON ULTRA-WIDE BANDWIDTH | TIMILSINA, SHARAD | — |
| 18037057 | APPLICATION OF SCTAG IN PREPARATION OF KIT USED TO DIAGNOSE GASTRIC CANCER | DUNN, MCKENZIE A | — |
| 18349353 | APPLICATION OF ANTISENSE OLIGONUCLEOTIDE TARGETING PBX1 PROMOTER REGION G-QUADRUPLEX IN PREPARATION OF MEDICINE FOR TREATING MELANOMA | ANGELL, JON E | — |
| Art Unit | Apps |
|---|---|
| 2855 | 1 |
| 2884 | 1 |
| 1678 | 1 |
| 1637 | 1 |
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18769988 | BIONIC REGULATION METHOD FOR NUMBER OF BOUNCES OF DROPLET ON METAL SURFACE BASED ON ACOUSTIC IN-SITU MONITORING | FRANK, RODNEY T | 2855 | §112 | Final Rejection | — | Pending | Jul 11, 2024 |
| 18758054 | SOIL NITROGEN CONTENT SOFT MEASUREMENT METHOD BASED ON THE CONTROL SYSTEM FOR ON-DEMAND FERTILIZATION OF CORN | SATANOVSKY, ALEXANDER | — | §101 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18622962 | CHIP-LEVEL POSITIONING METHOD FOR ORTHOPEDIC SURGERY NAVIGATION BASED ON ULTRA-WIDE BANDWIDTH | TIMILSINA, SHARAD | — | §103§112 | Non-Final OA | — | Pending | Mar 31, 2024 |
| 18414426 | METHOD FOR HIGH PRESSURE REGULATION AND CONTROL OF PHOTOELECTRIC DETECTION BASED ON BiOBr | MALEVIC, DJURA | 2884 | §103 | Final Rejection | — | Pending | Jan 16, 2024 |
| 18037057 | APPLICATION OF SCTAG IN PREPARATION OF KIT USED TO DIAGNOSE GASTRIC CANCER | DUNN, MCKENZIE A | 1678 | §101§112 | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18349353 | APPLICATION OF ANTISENSE OLIGONUCLEOTIDE TARGETING PBX1 PROMOTER REGION G-QUADRUPLEX IN PREPARATION OF MEDICINE FOR TREATING MELANOMA | ANGELL, JON E | 1637 | §102§103§112 | Non-Final OA | — | Pending | Jul 10, 2023 |
| 17834161 | CROP YIELD PREDICTION METHOD AND SYSTEM | STUBBS, JOHN THOMAS | 1686 | §101§103 | Non-Final OA | 2d overdue | Pending | Jun 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial